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ABSTRACT 
Genome-wide association studies (GWAS) have revealed numerous loci for areal bone mineral density 
(aBMD). We completed the first GWAS meta-analysis (N=15,275) of lumbar spine volumetric BMD 
(vBMD) measured by quantitative computed tomography (QCT), allowing for examination of the 
trabecular bone compartment.  SNPs that were significantly associated with vBMD were also examined 
in two GWAS meta-analyses to determine associations with morphometric vertebral fracture in 
(N=21,701) and clinical vertebral fracture (N=5,893). Expression QTL analyses of iliac crest biopsies 
were performed in 84 postmenopausal women, and murine osteoblast expression of genes implicated 
by eQTL or by proximity to vBMD-associated SNPs was examined. We identified significant vBMD 
associations with five loci, including 1p36.12, containing WNT4 and ZBTB40; 8q24, containing 
TNFRSF11B; and 13q14, containing AKAP11 and TNFSF11. Two loci (5p13 and 1p36.12) also 
contained associations with radiographic and clinical vertebral fracture, respectively. In 5p13, 
rs2468531 (minor allele frequency [MAF]=3%) was associated with higher vBMD (β = 0.22, p = 1.9 x 
10
-8
) and decreased risk of radiographic vertebral fracture (OR = 0.75; false discovery rate [FDR] p = 
0.01). In 1p36.12, rs12742784 (MAF=21%) was associated with higher vBMD (β = 0.09, p = 1.2 x 10-
10
) and decreased risk of clinical vertebral fracture (OR =0.82; FDR p = 7.4 x 10
-4
). Both SNPs are non-
coding and were associated with increased mRNA expression levels in human bone biopsies: 
rs2468531 with SLC1A3 (β = 0.28, FDR p = 0.01, involved in glutamate signaling and osteogenic 
response to mechanical loading) and rs12742784 with EPHB2 (β = 0.12, FDR p = 1.7 x 10-3, functions 
in bone-related ephrin signaling). Both genes are expressed in murine osteoblasts. This is the first study 
to link SLC1A3 and EPHB2 to clinically relevant vertebral osteoporosis phenotypes. These results may 
help elucidate vertebral bone biology and novel approaches to reducing vertebral fracture incidence. 
This article is protected by copyright. All rights reserved 
 
KEY WORDS: BONE QCT/µCT; ANALYSIS/QUANTITATION OF BONE; OSTEOPOROSIS; DISEASES AND DISORDERS 
OF/RELATED TO BONE; GENERAL POPULATION STUDIES; EPIDEMIOLOGY, HUMAN ASSOCIATION STUDIES; 
GENETIC RESEARCH; FRACTURE RISK ASSESSMENT; PRACTICE/POLICY-RELATED ISSUES 
  
This article is protected by copyright. All rights reserved 4 
INTRODUCTION 
Vertebral osteoporosis and fracture are substantial sources of pain, height loss, and mobility 
limitation in older adults(1). Not only has the burden of these conditions increased with the aging of 
populations, but the age-specific incidence of vertebral fracture has risen or remained steady even as 
the incidence of hip and other osteoporotic fractures has declined.(2-4)  Risk of fracture correlates with 
lower vertebral bone mineral density (BMD)(5) that declines with age, leaving the bone susceptible to 
compression and deformation even in the absence of traumatic force.   
Both vertebral BMD and fracture are heritable,(6) and multiple genetic loci have been 
associated with BMD as determined by dual x-ray absorptiometry (DXA) through large-scale GWAS 
meta-analyses.(7,8) Far fewer loci – either from BMD candidate genes or from GWAS — have been 
linked to fracture risk, even in large samples(9,10). This is likely due to several factors, including the 
multifactorial causation of fracture, heterogeneity of fracture risk by skeletal sites, and the inability of 
DXA BMD to completely define bone strength and fracture risk.  
Vertebral bone is unique in that its source of strength comes to a large extent from the 
trabecular compartment, with relatively little cortical area compared to other load-bearing skeletal sites.  
Quantitative computed tomography (CT) of the vertebrae allows for volumetric BMD measures of the 
trabecular compartment specifically, which are more strongly associated with vertebral fracture than 
areal BMD measures.(11) Areal BMD measured by DXA is confounded by bone size. In contrast with 
DXA, CT-based measurements of the spine allow for exclusion of vertebral elements and artifacts, 
including osteophytic or extra-skeletal calcification that is common in older adults.(12,13) For these 
reasons, we undertook a GWAS meta-analysis of quantitative CT-based volumetric BMD in the lumbar 
spine in older men and women, and we evaluated the resulting associations in separate meta-analyses 
of vertebral fracture.  
 
METHODS 
Study Design and Participants 
Cohort design and characteristics are described in Supplemental Table 1.  
 
Discovery studies: Six cohorts of men and women of European descent with CT imaging of the L2 or 
L3 spine were included in a discovery meta-analysis of trabecular volumetric BMD (vBMD, 
N=12,287).  Discovery cohorts included Age Gene/Environment Susceptibility-Reykjavik Study 
(AGES-Reykjavik)(14), Framingham Osteoporosis Study(6,15), Family Heart Study, Health Aging and 
Body Composition (Health ABC), Multi-Ethnic Study of Atherosclerosis (MESA)(16), and 
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Osteoporotic Fractures in Men (MrOS)(17). Except for Health ABC, the cohorts also had an integral 
vBMD (N=11,080) phenotype at the same lumbar vertebra. All participants were adults, and the mean 
age in each cohort ranged from 52 to 76 years (Supplemental Table 1). 
 
Replication studies: Replication of trabecular vBMD associations were done in silico in the Diabetes 
Heart Study (DHS, N=967) and with de-novo genotyping on selected SNPs in an additional sample 
from the AGES-Reykjavik cohort (N=2,020).  
 
Fracture studies: Two of the discovery cohorts (Framingham and MrOS) and five additional cohorts 
(MrOS-Sweden, Rotterdam I-III, Study of Osteoporotic Fractures [SOF]) contributed to the evaluation 
of trabecular vBMD-associated loci for their association with radiographic vertebral fracture 
(N=21,701; 23% fracture cases).  
 
Lumbar Spine CT Phenotypes 
CT scans of the spine provided vBMD phenotypes at either L2 or L3 (Figure 1). In cohorts with 
vBMD measured at adjacent levels, correlations were high (r=0.89-0.93). CT scanners and software 
used in each cohort are listed in Supplemental Table 1. In MESA, CT data were analyzed using Image 
Analysis Volumetric Software, and the remaining cohorts were analyzed using software developed by 
one author (TL).(18) In order to ensure regions of interest were defined consistently across cohorts, two 
authors (TL and MB) evaluated phenotype definitions. The tissue density of the analyzed volume 
calibrated to units of equivalent concentration of hydroxyapatite in g/cm
3 
yielded the BMD values. The 
following two BMD phenotypes were analyzed: 
Trabecular volumetric BMD (vBMD) is the average density in g/cm
3
 of all the voxels contained 
within the boundary of the trabecular region. This measure was calculated from a single slice of the 
region encompassing most of the trabecular bone in the vertebral body (Figure 1).  
Integral vBMD is the average density in g/cm
3
 of all the voxels contained within the periosteal 
edge of the vertebral body, excluding all of the posterior elements (Figure 1).  
 
Vertebral Fracture Phenotypes 
Two separate fracture GWAS meta-analyses were conducted on non-overlapping population 
samples. Radiographic vertebral fracture is often asymptomatic and was evaluated by imaging in cohort 
studies of older men and women (described below). On the other hand, clinical vertebral fracture was 
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defined (as described in the attached manuscript by Lopez et al.) by signs and symptoms such as back 
pain, height loss, and kyphosis and was confirmed by imaging.  
 
Radiographic vertebral fracture: These studies included prevalent and incident fracture evaluated 
from T4 to L4. Prevalent radiographic vertebral fracture was defined for each cohort as described in 
Supplemental Table 1. Prevalent vertebral fracture was defined by Genant’s scale(19) or by using 
vertebral body height ratios >3SD(20,21),  evaluated by visual semi-quantitative readings or 
quantitative assessments with review by a radiologist. In three cohorts (MrOS(22), Rotterdam I and II), 
incident radiographic vertebral fracture was also included in the case definition. Between 15% and 22% 
of each cohort were cases. 
 
Clinical vertebral fracture: Nine clinic- or population-based case-control or cohort studies were 
included in the GWAS of this phenotype. All participants were postmenopausal women age 45 or older 
from Europe or Australia. Cases were matched with controls from the same geographical region or 
same ethnic background. 
 
Genotyping and Imputation 
Genome-wide genotyping was followed by imputation of non-genotyped SNPs up to 2.7 million SNPs 
using the HapMap II reference panels. Details of each cohort’s genotyping and imputation methods are 
provided in Supplemental Table 2. Replication genotyping for 13 SNPs in the AGES cohort was done 
using TaqMan at LGC Genomics. 
 
Statistical Analysis 
Association analyses were performed in each study first and then meta-analyses were applied to 
combine results from each study.  Within each study, a z-score transformation of BMD phenotypes was 
applied.  A general linear regression model with the additive genetic effect was applied to test for 
association between each BMD phenotype (Z-score) and each autosomal SNP.  In the regression 
model, we adjusted for  age, age
2
, weight (kg),  and principal components for ancestral genetic 
background and study specific covariates (such as study site). In mixed-sex cohorts, sex was included 
as an adjustment variable in the regression model. Sex-stratified results were also provided.  In the 
Framingham Osteoporosis Study and the Family Heart Study, a linear mixed effects model with within-
family correlations as a random effect was used to account for relatedness among participants. In the 
Diabetes Heart Study, a random effects model was implemented using Sequential Oligogenic Linkage 
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Analysis Routines (SOLAR) version 6.3.4 (Texas Biomedical Research Institute, San Antonio, TX, 
USA) as previously described (23,24). The kinship coefficient matrix used was verified by the 
genotypic data via the software KING. The fixed-effect inverse-variance meta-analyses were 
performed by two authors (YH and CN) independently.  Meta-analysis results were filtered by sample 
size (< half of the total sample size), number of studies with available results (< 3 cohort studies), 
overall MAF (< 1%) and the heterogeneity test across studies (I
2 ≥ 50 or p-values for heterogeneity 2 
test q 5 x 10
-5
). Genome-wide significance (GWS) level was defined as p-value < 5 x 10
-8
, and 
suggestive significance level was defined as p < 5 x 10
-6
 after adjusting for genomic control λGC value 
within each cohort and after meta-analysis. Double genomic control was applied to the integral vBMD 
GWAS after observing an elevated λGC value. Q-Q and Manhattan plots were generated in R 3.2.2 
using plyr and qqman packages (Supplemental Figures 1 and 2). For GWS and suggestive SNPs, effect 
sizes were evaluated for heterogeneity between sexes using fixed-effect inverse-variance meta-analysis. 
 
Conditional associations:  To identify whether SNPs that were associated with trabecular vBMD or 
integral vBMD were independent from (not in LD with) SNPs that were reported to be associated with 
DXA BMD at the lumbar spine,(8) we performed a conditional analysis using the GCTA (Genome-
wide Complex Trait Analysis) tool package.(25,26) For GWS and suggestive loci, we conditioned on 
reported BMD GWAS SNPs (associated with lumbar spine BMD measured by DXA). We selected 
SNPs for replication genotyping that were associated with CT BMD (trabecular vBMD or integral 
vBMD) independently from SNPs associated with DXA BMD based on conditional analyses.  After 
genotype quality control, thirteen SNPs were available for inclusion in meta-analyses of discovery and 
replication.  
 
Association with radiographic vertebral fracture: The most significant SNP at each GWS or 
suggestive trabecular vBMD locus (n=12) was evaluated for its association with radiographic vertebral 
fracture using logistic regression, with results combined across cohorts using fixed-effect inverse-
variance meta-analysis. In each cohort, adjustments for age, height, and weight were performed. In 
mixed-sex cohorts, sex adjustment was also included.  In addition, results for each of the 12 SNPs were 
examined in an independent meta-analysis of clinical vertebral fracture (N=5,893, Lopez et al., 
submitted manuscript attached to this submission for your review).  False-discovery rate p-values were 
calculated, and the direction of effect relative to that for trabecular vBMD was used to evaluate 
consistency across phenotypes (e.g., an OR>1 for fracture is consistent with a negative β for trabecular 
vBMD).  
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Expression Quantitative Trait Loci (eQTLs) Analysis 
We conducted cis-expression quantitative trait locus (eQTL) analysis within a 2Mb flanking 
region (1Mb upstream and 1 Mb downstream) of each of the top SNPs to evaluate whether they 
influence transcript levels of genes in human pelvic crest bone biopsies(27) and human primary 
osteoblasts.(28)  Expression experiments in human whole bone biopsies and human primary osteoblasts 
were conducted in different study samples. For details of genotyping and microarray expression 
profiling, see Supplemental Methods. For eQTL analyses, a linear regression model with the additive 
genetic effect was used. We adjusted for age, weight, cigarette smoking and genetic ancestry in the 
regression model.  Locus-wide statistical significance was defined as false discovery rate (FDR) Q-
values < 0.05 in each locus.   
 
Primary Murine Osteoblasts 
Gene expression profiles of six candidate genes near genome-wide associated SNPs were 
examined in primary mouse osteoblasts undergoing differentiation.  These data have been described in 
detail previously(29) and are freely available from the Gene Expression Omnibus (GSE54461). For 
details, see Supplemental Methods. 
 
In-silico Annotation and Enrichment Analyses  
  Since all GWS and suggestive SNPs were non-coding (either intronic and intergenic SNPs), as 
were all SNPs in high LD with them, we annotated potential regulatory functions of those SNPs based 
on experimental epigenetic evidence including chromatin states, DNAse hypersensitive sites, histone 
modifications, phylogenetic conservation, altered regulatory motifs for transcription factor binding sites 
in human tissues, primary cells and cell lines from the ENCODE Project and the Roadmap 
Epigenomics Project(30,31). This was done by searching the HaploReg4 web browser.(32)  Position 
weight matrices (PWMs) of a motif sequence were scored for instances that passed a threshold of p < 4 
x 10
-7
.  Only instances where a motif in the sequence passed the threshold of a PWM in either the 
reference or the alternate genomic sequence with variable nucleotide(s) (thus changing the PWM score) 
were considered.  The enhancer and promoter states were obtained by ChromHMM(33) and were 
visualized using the WashU Epigenome Browser (http://epigenomegateway.wustl.edu/).  
To evaluate whether top-associated SNPs were enriched with regulatory elements in specific tissues 
(such as bone relevant tissues, including primary osteoblast, bone-marrow-derived stem cell, or 
mesenchymal progenitor cells available in the ENCODE and the Roadmaps Epigenomics Project), a 
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hypergeometric test was performed and permutation was used to estimate enrichment p-values. Since 
our imputation was based on the reference panel that is not generated by whole genome sequencing 
(international HapMap Project Phase II reference panel), we expected that our top associated SNPs 
may predominantly serve only as surrogate markers that are in high LD with the un-genotyped and un-
imputed functional SNPs that are responsible for GWAS signals.  Therefore, we extended our in-silico 
functional annotation and enrichment analysis to those common SNPs (MAF > 1% based on 1000 
Genomes Project Phase I version 3 CEU references) that are in high LD (r
2
 > 0.8 based on 1000 
Genomes Project Phase I version 3 CEU references) with the most significant SNP in each locus.  
 
RESULTS 
BMD and Fracture Associations 
Five loci had genome-wide significant (GWS, p < 5x10
-8
) associations with trabecular 
volumetric BMD (vBMD) in the meta-analysis of discovery (6 cohort studies) and replication cohorts 
(2 cohort studies, combined N=15,275). These included four loci marked by common SNPs (MAF ≥ 
5%) located in 1p36.12 (near WNT4, ZBTB40), 1p43 (GREM2), 8q24 (TNFRSF11B), and 13q14 
(TNFSF11, Table 1). All except for GREM2 have been previously associated with lumbar spine areal 
BMD. In addition, in the 5p13 locus, which has not previously been linked to lumbar spine BMD, the 
most significantly associated SNP with trabecular vBMD was rs2468531 (MAF = 3%). All GWS SNPs 
were intronic or intergenic (Supplemental Figure 3). There was no significant heterogeneity of effect 
sizes between sexes for these SNPs (Supplemental Figure 4). All GWS SNPs associated with trabecular 
vBMD were also strongly associated with integral vBMD and had similar effect sizes, although not all 
of the trabecular vBMD GWAS SNPs achieved genome-wide significance for integral vBMD, perhaps 
because of the smaller sample size with integral vBMD measurements (Supplemental Table 3). An 
additional 6 loci had common SNPs with suggestive-significant associations (5x10
-8
 < p < 5x10
-6
) with 
trabecular vBMD, and only one of these (6q25) reached a suggestive significance level for integral 
vBMD (Supplemental Table 3).  An additional 9 loci had SNPs that were suggestively associated with 
integral vBMD, though only 2 were suggestive after double GC adjustment (Supplemental Table 3).  
Among them, the most significantly associated SNP, rs3786178 (MAF = 2%) near CTIF on 18q21.2, 
had a relatively strong association (standardized β = 0.19, p = 1.86 x 10-6).  
Among SNPs associated with trabecular vBMD or integral vBMD (listed in Table 1) with 
p<5x10
-6
, only rs2468531 (5p13, near SLC1A3) was found to be associated with radiographic vertebral 
fracture after correction for multiple testing (odds ratio [OR] = 0.75 per minor allele, FDR p-value = 
0.01, Table 2, Figure 2). The same SNP was nominally associated with clinical vertebral fracture (OR 
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= 0.66, p = 0.01, see the Lopez et al. manuscript attached to this submission, but FDR p = 0.07). 
Among SNPs associated with trabecular vBMD (listed in Table 1), the GWAS SNP rs12742784 near 
ZBTB40 was associated with clinical vertebral fracture (OR = 0.82, FDR p = 7.4 x 10
-4
).  Although 
SNPs at other loci (GREM2, C6orf97, ATP2B1) were nominally significantly associated with vertebral 
fracture, no other ORs were nearly as strong as for rs2468531 or rs12742784 (Table 2).  
 
cis-Expression Quantitative Trait Loci (cis-eQTLs) in Human Bone Biopsies 
The cis-eQTL results of the whole bone biopsies are shown in Table 3. For genome-wide significant 
SNPs, we found two significant eQTLs after multiple testing correction. First, SNP rs12742784 in the 
1p36.12 locus was associated with increased expression of EPHB2, about 355 kb downstream (β = 
0.12, FDR p = 1.72x10
-3
), but was only marginally associated (p = 0.08) with ZBTB40, the nearest gene 
in this GWAS locus (about 96 kb downstream). The other significant cis-eQTL finding was for SNP 
rs2468531 in the 5p13 locus, which was associated with increased expression of SLC1A3, 126 kb 
downstream from the associated SNP (β = 0.28, FDR p = 0.01).  A suggestive SNP, rs2941584, was 
associated with EML6 expression in the 2p21 locus (FDR p = 0.04); and a suggestive SNP rs7301013 
with WNT5B expression in the 12p13.3 locus (FDR p = 0.01).  In most cases, the most significantly 
associated cis-eQTL gene in each locus was not the gene nearest to the top associated SNP, a 
phenomenon also observed in other studies(34). CCDC91 was filtered out due to low signal values in 
the microarray.   
 
Expression in Mouse Osteoblasts 
Ten of the eleven genes located near a trabecular vBMD locus or implicated through eQTL 
analysis were expressed during murine osteoblastogenesis, and each presented with a unique level 
and/or pattern of expression. EphB2 maintained a consistent level of expression over time, whereas 
Slc1a3 expression rose rapidly through the period of rapid cell proliferation and reached a plateau 
coincident with a phase associated with increased expression of extracellular matrix genes (~day 8-10, 
Supplemental Figure 5). Of the two genes near 1q43, Grem2 expression was extremely high during the 
period of cell culture associated with rapid growth and cell division. Expression of this gene decreased 
and entered a steady state plateau at about day 8 post differentiation. Like Grem2, Fmn2 showed a 
pattern of decreasing expression during osteoblastogenesis; however, expression of this gene was very 
low at all points examined. Both Akap11 and Zbtb40 demonstrated constant expression during 
osteoblast maturation (Supplemental Figure 5).  
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In-silico Annotation of Non-Coding SNPs and of SNPs in LD with the Top Associated SNPs 
Evaluation of whether the top-associated SNPs (from Table 1) were enriched with regulatory 
elements in specific tissues showed the most significant enrichment for the cortex derived primary 
cultured neurospheres (E053) with enrichment p-value = 9.56x10
-3
. We observed 3 SNPs (out of 12) 
overlapping with regulatory elements in the cortex neurospheres (ENCODE, Supplemental Tables 4 
and 5), compared to the 0.5 expected SNPs overlapping with regulatory elements in the same cell type 
if we randomly select 12 SNPs with the same MAF and LD pattern across the whole genome. After 
multiple testing corrections by FDR, the enrichment in the cortex neurospheres became non-significant. 
Two common nonsynonymous SNPs were found to be in LD with the top associated SNPs. 
SNP rs2073618 (N3K) (discovery p-value=1.41 x 10
-6
) in TNFRSF11B is in high LD (r
2
=0.88) with 
rs1485303, and SNP rs35737760 (D859E) in CACNA1E is in high LD with SNP rs7301013 that was 
suggestive for integral vBMD. However, both variants were predicted not to affect protein function due 
to the corresponding amino acid substitution based on the conservation-based SIFT package and were 
predicted to be benign by PolyPhen-2. All common SNPs in high LD with top associated SNPs in all 
other loci were either intronic or intergenic. Twelve of the 21 loci with GWS or suggestive trabecular 
vBMD or integral vBMD associations had SNPs in LD that were located in either predicted enhancer 
or promoter regions in one of the three bone-relevant cell types: osteoblast primary cells, mesenchymal 
stem cell derived chondrocyte cultured cells, and bone marrow derived mesenchymal cultured cells 
(E129, E049 and E026, Supplemental Table 5).  These included intronic or intergenic SNPs in the 
GWS trabecular vBMD loci near GREM2, TNFRSF11B, and TNFSF11, as well as the 5p13 locus.  Of 
note, the GREM2 locus (1q43) has quiescent annotations across an abundance of cell types except for 2 
SNPs, rs1414660 (r
2
 for LD with top vBMD SNP = 0.87; discovery p-value=2.01 x 10
-10
) and 
rs9659023 (not analyzed), which are both located in an enhancer region that is specifically active in 
bone marrow derived mesenchymal cells, osteoblasts and other mesenchymal cells, suggesting a cell-
type specific gene regulation in those bone-relevant cells. The rs1414660 regulatory sequence is under 
evolutionary constraint, as estimated by GERP and SiPhy 
(http://www.broadinstitute.org/mammals/haploreg/detail_v4.1.php?query=&id=rs1414660). 
Furthermore, the rs1414660 intronic single nucleotide change was predicted to perturb conserved 
regulatory motifs for bone-relevant transcription factors, such as CEBPa, CEBPb and others 
(Supplemental Table 6). The 5p13 locus is quiescent except for a region surrounding the indel 
rs148073475 
(http://www.broadinstitute.org/mammals/haploreg/detail_v4.1.php?query=&id=rs148073475). To 
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evaluate whether these 12 SNPs in LD with variants are specifically located in enhancer regulatory 
regions for three bone-relevant cells we tested for enrichment in regulatory regions in tissues other than 
bone relevant tissues. We performed hypergeometric tests in 127 cell types and tissues from the 
Roadmap Epigenomics Project but did not find significant enrichment, suggesting that these selected 
SNPs are enriched only in bone-specific gene regulatory regions. 
 
DISCUSSION  
Through these meta-analyses of vertebral trabecular vBMD and fracture, we identified two loci 
associated with lumbar spine BMD, vertebral fracture, and human bone expression of genes that were 
also expressed in mouse osteoblasts. One is a novel BMD locus, at 5p13, and the minor alleles of the 
most significantly associated SNPs had a lower frequency (3%), stronger positive associations with 
trabecular vBMD (β = 0.22), and lower risk of fracture (OR = 0.75) than did other variants associated 
with BMD or fracture in this study. Cis-eQTL analyses in human bone and mouse osteoblast 
expression studies suggest that the SLC1A3 gene, which is ~126 kb upstream of SNP rs2468531, may 
be the gene in this locus involved in bone modeling/remodeling.  Common variants in another locus, 
1p36.12, were significantly associated with trabecular vBMD, fracture (clinical vertebral OR: 0.82, 
FDR p = 7.4 x 10
-4
) and expression of EPHB2, providing an explanation for the associations with BMD 
phenotypes consistently reported in this region(8,35-37). This is the first study to link EPHB2 
expression to vertebral phenotypes in humans. The finding that these loci are associated with both 
vertebral trabecular BMD and vertebral fracture reinforces their clinical importance. Our expression 
studies suggest a regulatory function for the causal variants underlying these SNP associations.   
SLC1A3: Previous studies have reported that the SLC1A3 gene is involved in glutamate 
signaling necessary for osteogenic response to mechanical loading.(38) SLC1A3 (aka GLAST or 
EAAT1) is a glutamate transporter expressed in human as well as rat and mouse osteoblasts and 
osteocytes, discovered through its down-regulation in osteocytes in response to osteogenic mechanical 
loading(39). SLC1A3 has been found to be expressed in most human tissues/cells, especially in brain 
and neurons. Although a Slc1a3 mouse knock-out showed no differences in multiple femoral bone 
phenotypes through age 6 months,(40) there has been no examination of either vertebral bone 
phenotypes or of aged mice in such a knockout.  These are important distinctions, as Slc1a3 knockout 
effects on another phenotype have been shown to depend on advanced age,(41) and axial and 
appendicular skeletal regions are known to have distinct patterns of development and regulation over 
the course of development (e.g., (42-44)).  
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SLC1A3 associations have not been reported to be genome-wide significantly associated with 
aBMD in any previous study. In the most recent lumbar spine aBMD GWAS meta-analysis, the most 
significant SNP in this locus was rs2468531 (MAF=4.8%, β = 0.077, p = 7.4 x 10-3) (29). That aBMD 
GWAS meta-analysis had much larger sample size and included many of the participating studies in 
our CT GWAS meta-analysis. It is unclear whether the difference in phenotype or underlying 
population differences contributed to this discrepancy. Previously reported cell and animal model 
evidence for SLC1A3 suggests its biological function in bone physiology may interact with  mechanical 
loading and aging; therefore, it may be fruitful to evaluate such interactions with potentially causative 
SLC1A3 SNPs in future studies. 
EPHB2: Our findings suggest that regulation of the Ephb2 gene contributes to the previously 
reported associations with BMD and fracture at the 1p36.12 locus. ZBTB40 has been consistently 
linked to both spine and hip BMD as well as fracture risk(8,35-37) but has an unknown role in bone 
development or maintenance. ZBTB40 was expressed in osteoblasts in our study, but the associated 
(intergenic) SNP was unrelated to any regulatory element in ENCODE.  This gene is often reported 
concurrently with WNT4 associations with BMD; however, LD patterns and conditional analyses 
support the existence of two separate signals in this region of chromosome 1p36.12(8). In addition, cis-
eQTL analysis did not find significant associations between GWAS SNPs and ZBTB40 and WNT4 gene 
expression in whole bone. On the other hand, a cis-eQTL in this locus was found for the EPHB2 gene. 
The EPHB2 gene encodes a member of the Eph receptor family of receptor tyrosine kinase 
transmembrane glycoproteins.  Several in vitro and animal studies have found that Ephb2 is involved in 
bone development,(45) homeostasis,(46) and fracture repair(47), as well as skeletal response to 
PTH(48) and IGF(49). This is the first study to link genetic variation in humans to EPHB2 expression 
and clinically important vertebral phenotypes. 
GREM2: One additional locus associated with trabecular vBMD, an intronic SNP, rs9661787, 
in FMN2 and near GREM2, has not previously been reported for lumbar spine BMD by DXA.  It has, 
however, been linked to trabecular BMD of the distal tibia, as measured by peripheral quantitative CT 
(pQCT), and was demonstrated to affect trabecular number and thickness as evaluated by 
HRpQCT.(50)  In the current analyses, the FMN2/GREM2 SNP was also associated with integral 
vBMD with a similar effect size, perhaps because of the sizeable contribution of trabecular vBMD in 
the overall measure of integral vBMD by CT of the lumbar spine. The homologous region in mice 
(174.8 Mb on Chromosome 1) has consistently been associated with BMD phenotypes, including 
vertebral BMD.(51)  In addition, our GWAS SNP rs9661787 in the FMN2/GREM2 locus is in high LD 
(r
2
=0.88) with a GWAS SNP (rs9287237) identified previously for a  pQCT GWAS.(50)  SNP 
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rs9287237 had similar effect sizes to our top SNP for trabecular vBMD and integral vBMD in this 
study.  
SNP rs9287237 was robustly associated with GREM2 expression in human osteoblasts.(50) 
Each additional T allele of rs9287237 was associated with decreased expression of GREM2 in human 
osteoblasts, increased trabecular BMD and decreased fracture risk.(50) In our eQTL analysis, we also 
found SNP rs9287237 was associated with lower GREM2 expression in human whole bone biopsies, 
though the association was not statistically significant. GREM2 (aka PRDC and Gremlin2) is an 
extracellular antagonist of bone morphogenetic proteins (BMPs), and loss of this factor allows for an 
increase in osteoblastic differentiation.(52-54) We observed a marked decrease in expression of Grem2 
as these cells transitioned from a committed but immature cell to a fully mature osteoblast in mouse.  
This suggests that Grem2 is an inhibitor of osteoblast maturation and/or function and that expression of 
this gene must be reduced to allow this process to occur.  Our observation that GWAS SNP rs9661787 
was associated with lower GREM2 expression (Table 3) and associated with higher trabecular vBMD 
(Table 1, G allele of rs9661787) supports previous findings that Grem2 inhibited osteoblast maturation 
and/or function. Available data suggest that this gene is not expressed or is only marginally expressed 
in mouse osteoclasts (http://biogps.org).  Unlike for Grem2, expression of Fmn2 was barely detectable 
in osteoblasts.  This low/lack of expression of this gene in bone has been corroborated in other studies 
wherein whole bone, osteoblasts, osteoclast and osteoblast like cell lines were examined 
(http://biogps.org).  Together these data suggest that GREM2 is the more likely candidate at this locus.  
 
Four other loci had common SNPs that were genome-wide significantly associated with 
trabecular vBMD (near WNT4, ZBTB40, TNFRSF11B, and TNFSF11), although effect sizes were much 
smaller than for the 5p13 locus.  These loci have been consistently reported to be associated with 
lumbar spine BMD by DXA(8,28,29) and fracture.(10)  The roles of WNT4, TNFRSF11B, and 
TNFSF11 are well described in WNT-signaling and RANK/RANKL/OPG pathways, which are central 
to bone metabolism.(55)  Of particular relevance to our phenotype of spine BMD in older age, Wnt4 
has been demonstrated to prevent bone loss and one of its common causes, inflammation, by inhibiting 
NF-κB in macrophages and osteoclast precursors.(56)  The SNP, however, is predicted not to be 
constrained by SIFT and is benign by PolyPhen-2.  
 
Phenotypic considerations 
Volumetric BMD measured by CT has advantages over DXA BMD for evaluating genetic 
regulation specific to 3D structure and mineral density.  CT measures allow for the removal of bone 
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size from the phenotype, whereas DXA BMD is a 2D measured combination of size and density.  
Furthermore, DXA BMD of the lumbar spine includes the vertebral body and posterior elements, as 
well as other regions that are predisposed to degenerative changes.  Volumetric BMD measures, 
including trabecular and integral BMD, were more strongly associated with prevalent vertebral fracture 
than was areal spine BMD in a case-control study nested in the Framingham Osteoporosis Study.(11) 
Therefore, vBMD may be a more relevant phenotype for vertebral fracture risk. Although candidate 
gene analyses have discovered distinct associations with, e.g., vBMD and vertebral cross-sectional 
area(57), ours is the first GWAS of volumetric phenotypes in a multi-cohort meta-analysis and the first 
to link vBMD SNP associations to fracture and gene expression. 
  
Limitations 
Limitations of the study include a relatively small number (15,275) of participants with 
volumetric BMD phenotypes available. As a polygenic and complex trait, BMD requires very large 
sample sizes to detect the effect sizes often observed for common SNPs.  Of 49 loci associated with 
lumbar spine BMD in previous large GWAS meta-analyses,(8,29) we identified only 9 in our 
volumetric spine BMD traits. Whether this lack of confirmation of previously identified spine BMD 
associations is due to true phenotypic differences in association or simply lower sample size in the 
current study is unknown. However, 4 out of 6 trabecular vBMD GWAS loci found in the current study 
have been reported by previous BMD GWAS meta-analysis; and 4 out 6 trabecular vBMD suggestive 
GWAS loci have also been reported by a previous DXA-derived BMD GWAS meta-analysis, 
suggesting limited statistical power with relatively smaller sample size may play a major role in this 
lack of confirmation.  Further investigation of the involvement of those GWAS loci unique to the CT 
BMD will improve our understanding of the molecular regulation of bone.    
Moderate effect size for most of the common SNPs may also contribute to the limited statistical 
power that the current study has. The majority of common variants previously reported are closer to 
zero (|standardized β| ≤ 0.03) than the range of effect sizes we observed for GWS associations with 
volumetric BMD (0.057 ≤ |standardized β| ≤ 0.098), implying lack of power in this study to identify 
common SNPs with smaller effect sizes. Similarly, the study was not designed to detect less common 
(1% < MAF < 5%) or rare variants (MAF < 1%), and only two variants with 2% ≤MAF<5% (SLC1A3 
and CTIF) were found to be associated with trabecular vBMD or integral vBMD.  These had effect 
sizes approximately three times as large as the more common variants and were similar in effect size to 
that reported for a low-frequency variant in EN1 for vertebral BMD,(29) again underscoring the value 
of studying less common variants for skeletal phenotypes.  There are undoubtedly other genetic 
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contributors to BMD that will require studies powered to detect moderate effect sizes in low-frequency 
or rare variants. 
Limitations regarding heterogeneous radiographic vertebral fracture definitions have been 
described(9) and may have limited our power for observing fracture associations among the vertebral-
BMD associated loci.  However, we observed similar prevalence of fracture across the cohorts that 
were included (16-22%), indicating that differences in case definitions may result in ascertainment of 
similar cases in these studies. Three trabecular vBMD loci (near ZBTB40, FMN2/GREM2, and 
SLC1A3) were associated more strongly with clinical vertebral fracture than with radiographic vertebral 
fracture, indicating a potential for clinical fracture to give a stronger association signal than 
radiographic fracture for these variants.  
Several additional limitations of this study include limited statistical power to detect SNPs with 
moderate eQTL; imputation based on HapMap II reference panel rather than whole genome sequencing 
based 1000G reference panel, providing limited coverage of genetic variants across genomes; and 
limited bone-relevant tissues in existing databases for the in silico annotations of associated loci.  In 
addition, pinpointing causal variants and functionally validating them in cellular or animal models 
remain to be done. 
 Despite these limitations, we identified novel vertebral BMD and fracture associations related 
to SLC1A3 and EPHB2 expression. We also confirmed the importance of GREM2 and several genes 
involved in WNT-signaling for trabecular BMD and vertebral fracture in large cohorts of older adults. 
Our study reinforces the benefit of large-scale GWAS of more refined and clinically relevant skeletal 
phenotypes and the need for continued evaluation of noncoding genomic variants with potential 
regulatory function.   
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Table 1. Summary of associations with trabecular volumetric BMD (vBMD) 
Locus 
Position 
(build 36) 
SNP 
Nearest gene(s) (distance in 
kb)
1
  
A1/A2  
A1 
frequency 
  
Beta for 
A1 
SE 
Hetero-
geneity 
I
2
 
P value 
    
                
Discovery 
(N=12,287) 
Combined 
(N=15,275)
2
 
Combined p < 5x10
-8 
for trabecular vBMD 
1p36.12 22444772 rs12755933 WNT4 (103) C/G 0.27   -0.084 0.013 0 2.66 × 10
-10
 9.80 x 10
-11
 
1p36.12 22554953 rs12742784 ZBTB40 (96) C/T 0.21   0.094 0.015 0 1.18 × 10
-10
 1.05 x 10
-10
 
1q43 238659259 rs9661787 FMN2 (0)-GREM2 (60) C/G 0.81   -0.098 0.015 0 1.26 × 10
-10
 1.29 x 10
-11
 
5p13 36516441 rs2468531 SLC1A3 (126)-RANBP3L (179) G/C 0.03   0.221 0.037 0 1.47 × 10
-9
 1.91 x 10
-8
 
8q24 120045437 rs1485303 TNFRSF11B (12) A/G 0.44   -0.057 0.012 14.6 7.35 × 10
-7
 4.63 x 10
-9
 
13q14 41862203 rs17457561 AKAP11 (67) (TNFSF11 [700]) A/G 0.25   -0.095 0.014 0 1.95 × 10
-12
 1.12 x 10
-11
 
                        
Combined 5x10
-8
 ≤ p < 5x10
-6
 for trabecular vBMD 
2p21 54735125 rs2941584 SPTBN1 (0) C/T 0.32   -0.060 0.012 33.5 1.26 × 10
-6
 1.29 x 10
-7
 
6q25 151897286 rs10872673 C6orf97 (40) G/T 0.60   0.065 0.012 0 5.92 × 10
-8
 8.22 x 10
-7
 
12p13.3 2378832 rs7301013 CACNA1C (298) A/G 0.83   -0.076 0.016 39.4 1.45 × 10
-6
 4.90 x 10
-7
 
12p12.1 28183168 rs12813778 CCDC91 (118)-PTHLH (167) A/G 0.23   -0.068 0.014 32.9 1.16 × 10
-6
 2.35 x 10
-6
 
12q21.3 88861177 rs4842697 ATP2B1 (287) G/T 0.57   -0.057 0.012 22.4 9.09 × 10
-7
 2.60 x 10
-6
 
16p13.3 315783 rs9921222 AXIN1 (27) C/T 0.47   -0.059 0.012 0 6.09 × 10
-7
 4.90 x 10
-7
 
1 
Locus zoom plots are in Supplemental Figure 3. 
2 
Observations were added by new genotyping in AGES (n=2,021) and/or by in silico replication in DHS (n=967). The SNP association was considered to be replicated if 
the addition of the replication sample to the meta-analysis did not result in a p>5x10
-8
. 
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Table 2. Associations with vertebral fracture for SNPs with combined p < 5x 10
-6
 for trabecular volumetric BMD (vBMD) 
      Morphometric vertebral fracture (N=21,701)   Clinical vertebral fracture (N=5,893) 
Locus SNP Nearest gene(s)  
A1  
frequency 
OR P value 
FDR  
P value 
Hetero-
geneity 
I
2
 
  
A1 
frequency 
OR P value 
FDR  
P value 
Hetero-
geneity I
2
 
Combined p < 5x 10
-8
 for trabecular vBMD                     
1p36.12 rs12755933 WNT4 0.26 0.99 0.680 0.816 0   0.27 1.02 0.707 0.943 9.8 
1p36.12 rs12742784 ZBTB40 0.20 0.99 0.798 0.826 10.2   0.20 0.82 6.2 x 10
-5
 7.4 x 10
-4
 5.4 
1q43 rs9661787 FMN2-GREM2  0.82 1.06 0.102 0.306 48.7   0.82 1.12 0.055 0.220 0.1 
5p13 rs2468531 SLC1A3-RANBP3L 0.03 0.75 0.001 0.012 0   0.03 0.66 0.011 0.066 5.3 
8q24 rs1485303 TNFRSF11B  0.43 1.03 0.298 0.596 0   0.44 0.98 0.690 0.943 37.7 
13q14 rs17457561 AKAP11  0.24 1.02 0.516 0.788 0   0.27 0.95 0.343 0.686 0.0 
Combined 5x10
-8
 ≤ p < 5x10
-6
 for trabecular vBMD                   
2p21 rs2941584 SPTBN1 0.31 1.03 0.215 0.516 0 
 
0.33 1.08 0.096 0.230 18.2 
6q25 rs10872673 C6orf97 0.59 0.94 0.012 0.072 0   0.59 1.02 0.608 0.943 0.0 
12p13.3 rs7301013 CACNA1C 0.84 1.01 0.826 0.826 0   0.85 1.02 0.792 0.950 0.0 
12p12.1 rs12813778 CCDC91-PTHLH  0.23 0.98 0.525 0.788 75.7   0.24 1.10 0.081 0.230 0.0 
12q21.3 rs4842697 ATP2B1  0.59 1.05 0.038 0.152 47.0   0.59 1.00 0.948 0.981 0.0 
16p13.3 rs9921222 AXIN1 0.47 1.01 0.647 0.816 0   0.47 1.00 0.981 0.981 27.8 
OR: odds ratio, FDR: false-discovery rate 
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Table 3. Summary of associations with gene expression in human bone biopsies 
Locus 
Position 
(build 36) 
SNP Region 
Nearest gene(s) 
(distance in kb)  
Association with the 
nearest genes   
The most significant cis-eQTL 
          Beta P value   Gene Beta P value FDR P value 
Distance 
(kb) 
Combined p < 5x10
-8 
for trabecular vBMD 
1p36.12 22444772 rs12755933 intergenic WNT4 (103) 0.030 0.37   EPHB2 -0.062 0.02 0.34 465 
1p36.12 22554953 rs12742784 intergenic ZBTB40 (96) 0.105 0.08   EPHB2 0.120 3.49x10
-5
 1.72 x10
-3
 355 
1q43 238659259 rs9661787 intronic FMN2 (0) 0.027 0.27   GREM2 -0.049 0.10 0.61 60 
5p13 36516441 rs2468531 intergenic SLC1A3 (126) 0.279 4.36 x10
-3
   SLC1A3 0.279 4.36x10
-3
 0.01 126 
      intergenic RANBP3L (179) -0.107 0.33   
 
      
 8q24 120045437 rs1485303 intergenic TNFRSF11B (12) -0.019 0.61 
 
 NOV -0.136 0.04 0.53 452 
13q14 41862203 rs17457561 intergenic AKAP11 (67)  -0.068 0.03   AKAP11 -0.068 0.03 0.32 67 
      intergenic TNFSF11 (700) 0.035 0.28   
 
      
  
Combined 5x10
-8
 ≤ p < 5x10
-6
 for trabecular vBMD 
   
2p21 54735125 rs2941584 intronic SPTBN1  0.039 0.20   EML6 0.096 3.33 x10
-3
 0.04 69 
6q25 151897286 rs10872673 intronic C6orf97 (CCDC170) -0.003 0.92   MTHFD1L -0.090 0.03 0.28 433 
      intergenic ESR1 (160) 0.040 0.07   
 
      
 12p13.3 2378832 rs7301013 intronic CACNA1C 0.056 0.17   WNT5B 0.280 1.81 x10
-4
 0.01 752 
12p12.1 28183168 rs12813778 intergenic CCDC91 (118) n.a. n.a.   STK38L -0.068 0.03 0.15 813 
      intergenic PTHLH (167) -0.018 0.41   
 
      
 12q21.3 88861177 rs4842697 intergenic ATP2B1 (287) -0.093 0.02   ATP2B1 -0.093 0.02 0.13 287 
16p13.3 315783 rs9921222 intronic AXIN1 -0.033 0.27   POLR3K 0.102 2.57 x10
-3
 0.07 279 
 FDR: false-discovery rate 
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Figure 1. Cross-sectional view of the trabecular region of interest in the lumbar spine. Trabecular 
vBMD included this region only, while integral vBMD also included the cortical compartment. Both 
exclude the posterior elements that DXA measures of BMD incorporate, thus allowing CT measures to 
more precisely capture BMD of the vertebral body itself. 
 
 
 
Reprinted from Bone, Vol 44(4), Engelke K, Mastmeyer A, Bousson V, Fuerst T, Laredo J-D, Kalender 
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Figure 2. Beta coefficients and 95% CI for the additive effect of rs2468531 (SLC1A3) on trabecular 
vBMD (top) and morphometric vertebral fracture (bottom). Detailed study-specific results are provided 
in Supplemental Table 7. 
   
 
